Peptides DB
Research-centric peptide and protocol reference hub
Study 25 of 27Abaloparatide (Tymlos) literatureJOR spine · In vitro · Preclinical2026

Growth Plate Morphogens as Potential Modulators of Cellular Tissue Remodeling by Annulus Fibrosus Cells.

BMP-2, TGF-β1, and FGF-2 significantly influence AF cell behavior in vitro, suggesting potential roles in tissue remodeling relevant to AIS development.

Read at JOR spineAdd to compare

Where it sits

this study against the rest of the abaloparatide (tymlos) corpus
8
Preclinical · this one
8
Observational
0
Open-label
2
Randomised
9
Reviews

Summary and findings

The study investigated the effects of growth plate morphogens (GPMs) on annulus fibrosus (AF) cells in vitro. BMP-2, TGF-β1, and FGF-2 significantly altered gene expression related to ECM remodeling and cell proliferation. BMP-2 and TGF-β1 increased DNA content and sGAG levels, suggesting potential roles in tissue remodeling.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Higher DNA content under BMP-2 and TGF-β1 stimulation.Preclinical2026

Abstract

The authors’ words, as JOR spine supplied them

<h4>Background</h4>Adolescent Idiopathic Scoliosis (AIS) is a spinal deformity of unknown etiology that begins in the intervertebral disc and emerges during pubertal growth. In the vertebral growth plate, adjacent to the disc, powerful growth plate morphogens (GPMs) modulate this growth. We evaluated whether GPMs can also alter the capacity of annulus fibrosus (AF) disc cells to proliferate and/or remodel their extracellular matrix (ECM).<h4>Methods</h4>AF cell responsiveness to seven GPMs was screened in monolayer culture by RT-qPCR for downstream signaling markers. GPMs and concentrations eliciting significant transcriptional responses were selected for deeper analysis. Bulk RNA sequencing (RNA-seq) was conducted on AF cells cultured in a 2.5D environment to preserve their native elongated phenotype. Differentially expressed genes (DEGs) were identified and subjected to Gene Ontology enrichment, focusing on ECM remodeling and cell-proliferation processes. Transcriptomic findings were corroborated by assessments of cell proliferation (DNA content), sulfated glycosaminoglycan (sGAG) levels, and matrix metalloproteinase (MMP) activity.<h4>Results</h4>BMP-2, TGF-β1, and FGF-2 significantly altered AF cell expression of downstream target genes, whereas Ihh, PTHrP, Wnt-1, and FGF-18 did not. IGF-1 induced modest, dose-dependent gene expression changes that were not replicated by RNA-seq. BMP-2 and TGF-β1 upregulated genes associated with anabolic ECM remodeling. BMP-2 promoted a cartilage-like ECM with increased expression of type II-associated collagens, aggrecan, and hyaluronan synthesis. TGF-β1 promoted type I collagen-associated genes, collagen cross-linking, and myofibroblast activation. In contrast, FGF-2 activated transcriptional programs related to cell-cycle progression, collagen degradation, and increased GAG turnover. Functionally, we observed higher DNA content under BMP-2 and TGF-β1 stimulation and higher sGAG levels under BMP-2, TGF-β1, and FGF-2 treatment.<h4>Conclusion</h4>BMP-2, TGF-β1, and FGF-2 can modulate AF cell behavior, influencing tissue remodeling and implicating their involvement in disc wedging during AIS onset.

Background

Adolescent Idiopathic Scoliosis (AIS) is a spinal deformity that begins in the intervertebral disc and emerges during pubertal growth. Growth plate morphogens (GPMs) are known to modulate growth in the vertebral growth plate, which is adjacent to the disc. This study explores whether GPMs can influence the proliferation and extracellular matrix (ECM) remodeling capacity of annulus fibrosus (AF) cells, potentially contributing to AIS development.

Methods

The study screened AF cell responsiveness to seven GPMs in monolayer culture using RT-qPCR for downstream signaling markers. GPMs and concentrations eliciting significant transcriptional responses were selected for further analysis. Bulk RNA sequencing was conducted on AF cells in a 2.5D environment to maintain their native phenotype. Differentially expressed genes were identified and analyzed for Gene Ontology enrichment, focusing on ECM remodeling and cell proliferation. Transcriptomic findings were validated by measuring cell proliferation, sulfated glycosaminoglycan levels, and matrix metalloproteinase activity.

Results

BMP-2, TGF-β1, and FGF-2 significantly altered AF cell expression of downstream target genes, while other GPMs did not. BMP-2 promoted a cartilage-like ECM with increased type II collagen, aggrecan, and hyaluronan synthesis. TGF-β1 upregulated type I collagen-associated genes and myofibroblast activation. FGF-2 activated transcriptional programs related to cell-cycle progression and collagen degradation. Functionally, BMP-2 and TGF-β1 increased DNA content, and BMP-2, TGF-β1, and FGF-2 increased sGAG levels.

Interpretation

The study suggests that BMP-2, TGF-β1, and FGF-2 can modulate AF cell behavior, potentially influencing tissue remodeling and contributing to disc wedging in AIS. While the findings are statistically significant, the clinical significance remains uncertain due to the in vitro nature of the study. The results align with previous knowledge of GPMs' roles in growth plate modulation but require further validation in vivo to confirm their relevance to AIS.

Key findings

  • BMP-2, TGF-β1, and FGF-2 significantly altered AF cell gene expression.
  • BMP-2 promoted cartilage-like ECM with increased type II collagen and aggrecan.
  • TGF-β1 upregulated type I collagen-associated genes and myofibroblast activation.
  • FGF-2 activated genes related to cell-cycle progression and collagen degradation.
  • Higher DNA content observed under BMP-2 and TGF-β1 stimulation.

Limitations

  • In vitro study, limiting clinical applicability.
  • Cellular models may not replicate in vivo conditions.
  • No direct clinical endpoints assessed.

Elsewhere in the Abaloparatide (Tymlos) corpus

DSkeletal dysplasias of the parathyroid hormone signaling cascade: radiological manifestations and molecular mechanisms.Pediatric radiology · 2026reviewCThe distinct roles of PTHrP and PTH1R in long bone growth and digit formation.JBMR plus · 2026AnimalCTumor-derived Parathyroid Hormone-Related Protein Is Associated with Suppression of Cytochrome P450 Expression: Evidence From Multimodal Transcriptomics.ACS pharmacology & translational science · Not reported in abstract.AnimalBCase report: compound heterozygous &lt;i&gt;PTH1R&lt;/i&gt; variant(s) in a patient with inactivating PTH/PTHrP signalling disorder type 1 (iPPSD1).Journal of pediatric endocrinology & metabolism : JPEM · 2026 · n=1 · Not reported in abstract.HumanAAbaloparatide and pelvic fracture healing: a phase 2 randomized placebo-controlled trial.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2023 · n=48 · No significant difference in bridging score distribution (p=0.15) between ABL and PBO at 3 months.HumanAThe impact of parathyroid hormone replacement with palopegteriparatide on synthesis of 1,25-dihydroxy vitamin D in hypoparathyroidism.Expert review of clinical pharmacology · 2026 · Not reported in abstract.review